Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2014

View Archived Issues

Heptares achieves research milestone in antibody collaboration with MedImmune

Johnson & Johnson reports regulatory news of fourth quarter 2013

Identification of RNA transcription enzyme repressors as novel anticancer drugs

Dendrimer-enhanced docetaxel clinical trial to begin in patients with solid tumors

Amgen reports topline data from phase III GAUSS-2 trial

Kancera to develop a vaccine against ROR to prevent cancer relapse

BioLineRx receives FDA orphan drug designation for stem cell mobilization therapy

California Stem Cell submits phase II trial protocol to FDA for Ovapuldencel-T

Pfizer reports topline results from phase III study of ALO-02

CytRx begins phase II trial of aldoxorubicin for AIDS-related Kaposi's sarcoma

DiaGenic reports final results from exploratory study of blood test for Alzheimer's disease

MDxHealth and Teva Pharmaceuticals sign agreement to commercialize two cancer tests in Israel

Japanese researchers present novel GSK-3 inhibitors for cancer

Roche discloses new agents for HCV infection

FDA grants orphan drug status to Aeolus' drug candidate for treatment of acute radiation syndrome

Novel fatty acid synthase inhibitors patented by GlaxoSmithKline

Novel PCSK9 inhibitors designed by Cadila Healthcare for dyslipidemia

Isis Innovation divulges new RNA polymerase inhibitors for infections

Novartis to request re-examination of E.U. filing for serelaxin

EMA committee recommends approval of Xolair in new indication

Endo and BioDelivery report results from phase III trial of BEMA buprenorphine in chronic pain

Valeant completes acquisition of Solta Medical

KIF20A-derived peptide plus gemcitabine evaluated in pancreatic cancer trial

Previously identified RIP1 kinase inhibitor potentially useful for necroptosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...